Literature DB >> 31010597

Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands.

B G Taib1, S P Williams2, S Sood2, K Ung2, P P Nixon3, R Sharma2.   

Abstract

Botulinum toxin injections are useful in patients with refractory sialorrhoea although the optimum treatment protocol and its efficacy over a long period of follow up are controversial. The aim of our prospective study was to examine the efficacy and complications of a protocol of repeated ultrasound-guided botulinum toxin injections of fixed doses at a tertiary children's hospital. A total of 79 procedures were done in 34 patients who were followed up for two years. The overall complication rate was 3%. The outcome measures considered included the Drooling Frequency Severity Scale (DFSS), visual analogue scale (VAS), and carers' assessments of the reduction in drooling. Our study highlighted two types on non-responders (primary and secondary) of which 3/34 required definitive surgical management. In summary, this study shows that a protocol of repeated injections of fixed doses of botulinum toxin A, while not beneficial in all cases, is a potentially valuable option for the safe and effective treatment of sialorrhoea in children.
Copyright © 2019 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Botulinum Toxin; Drooling; Paediatric; Sialorrhoea

Year:  2019        PMID: 31010597     DOI: 10.1016/j.bjoms.2019.04.001

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  3 in total

Review 1.  Botulinum toxin A for the treatment of first bite syndrome-a systematic review.

Authors:  Noah E Shaikh; Haseeb A Jafary; John W Behnke; Meghan T Turner
Journal:  Gland Surg       Date:  2022-07

2.  Salivary gland ablation: introducing an interventional radiology treatment alternative in the management of sialorrhea.

Authors:  Katherine A Begley; Leah E Braswell; Garey H Noritz; James W Murakami
Journal:  Pediatr Radiol       Date:  2020-03-21

3.  Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children: SIPEXI.

Authors:  Steffen Berweck; Marcin Bonikowski; Heakyung Kim; Michael Althaus; Birgit Flatau-Baqué; Daniela Mueller; Marta Dagmara Banach
Journal:  Neurology       Date:  2021-08-02       Impact factor: 11.800

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.